Clinical Trials Study
Copyright ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Feb 16, 2017; 9(2): 77-84
Published online Feb 16, 2017. doi: 10.4253/wjge.v9.i2.77
Clinical utility of 0.025-inch guidewire VisiGlide2TM in the endoscopic retrograde cholangiopancreatography-related procedures
Yuji Sakai, Toshio Tsuyuguchi, Nobuto Hirata, So Nakaji, Kenji Shimura, Takao Nishikawa, Tatsuya Fujimoto, Tetsuya Hamano, Takayoshi Nishino, Osamu Yokosuka
Yuji Sakai, Toshio Tsuyuguchi, Osamu Yokosuka, Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Nobuto Hirata, So Nakaji, Department of Gastroenterology, Kameda Medical Center, Chiba 260-8670, Japan
Kenji Shimura, Takao Nishikawa, Department of Gastroenterology, Asahi Central Hospital, Chiba 260-8670, Japan
Tatsuya Fujimoto, Department of Gastroenterology, Kimitsu Central Hospital, Chiba 260-8670, Japan
Tetsuya Hamano, Takayoshi Nishino, Department of Gastroenterology, Tokyo Women’s Medical University Yachiyo Medical Center, Chiba 260-8670, Japan
Author contributions: Sakai Y, Tsuyuguchi T and Yokosuka O were responsible for study design and manuscript preparation; Sakai Y wrote the paper; Hirata N, Nakaji S, Shimura K, Nishikawa T, Fujimoto T, Hamano T and Nishino T were responsible for data collection.
Institutional review board statement: This study was conducted under our ethical committee.
Informed consent statement: All the treatment procedures were performed after obtaing the informed consent in writing from the patients.
Conflict-of-interest statement: The authors have no other disclosures.
Data sharing statement: I share data in the group of us.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Yuji Sakai, MD, Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, Inohana 1-8-1, Chuou-ku, Chiba 260-8670, Japan. sakai4754@yahoo.co.jp
Telephone: +81-43-2262083 Fax: +81-43-2262088
Received: July 13, 2016
Peer-review started: July 18, 2016
First decision: September 7, 2016
Revised: September 23, 2016
Accepted: November 1, 2016
Article in press: November 2, 2016
Published online: February 16, 2017
Abstract
AIM

To examine the result of the use of 0.025-inch guidewire (GW) VisiGlide2TM as the first choice in the endoscopic retrograde cholangiopancreatography (ERCP)-related procedures without selecting the patient in a multicenter prospective study.

METHODS

ERCP using 0.025-inch GW VisiGlide2TM as the first choice was conducted in patients who have needed ERCP, and its accomplishment rate of procedure, procedural time, incidence of accidental symptoms were compared with those of ERCP using 0.025-inch GW VisiGlideTM.

RESULTS

The accomplishment rate of procedure was 97.5% (197/202), and procedural time was 23.930 ± 16.207 min. The accomplishment rate of procedure using 0.025-inch GW VisiGlideTM was 92.3% (183/195), and procedural time was 31.285 ± 19.122 min, thus the accomplishment rate of procedure was significantly improved and procedural time was significantly shortened (P < 0.05). Accidental symptoms by ERCP-related procedures were observed in 3.0% (6/202), and all were conservatively alleviated.

CONCLUSION

When 0.025-inch GW VisiGlide2TM was used for ERCP-related procedure as the first choice, it showed high accomplishment rate of procedure and low incidence of accidental symptoms, suggesting it can be used as the universal GW. Clinical Trial Registry (UMIN0000016042).

Keywords: Endoscopic sphincterotomy, Endoscopic retrograde cholangiopancreatography, 0.025-inch guidewire

Core tip: When 0.025-inch guidewire (GW) VisiGlide2TM was used for endoscopic retrograde cholangiopancreatography-related procedure as the first choice, it showed high accomplishment rate of procedure and low incidence of accidental symptoms, suggesting it can be used as the universal GW.